Society guideline links: Anemia in chronic kidney disease

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

International

●Kidney Disease: Improving Global Outcomes (KDIGO): Clinical practice guideline for anemia in chronic kidney disease (2012)

●International Society of Nephrology (ISN): Clinical practice guidelines for assessment and management of iron deficiency (2008)

Canada

●Choosing Wisely Canada: Don't initiate erythropoiesis-stimulating agents (ESAs) in chronic kidney disease (CKD) patients with hemoglobin levels greater than or equal to 100 g/L without symptoms of anemia (2017)

●Canadian Society of Nephrology (CSN): Clinical practice guidelines and recommendations on peritoneal dialysis adequacy (2011)

●CSN: Clinical practice guidelines for assessment and management of iron deficiency (2008)

●CSN: Clinical practice guidelines for evaluation of anemia (2008)

●CSN: Clinical practice guidelines for evidence-based use of erythropoietic-stimulating agents (2008)

●CSN: Clinical practice guidelines for supplemental therapies and issues (2008)

●CSN: Introduction to the clinical practice guidelines for the management of anemia associated with chronic kidney disease (2008)

United States

●Kidney Disease Outcomes Quality Initiative (KDOQI): US commentary on the 2012 KDIGO clinical practice guideline for anemia in CKD (2013)

●Choosing Wisely: Don't administer erythropoiesis-stimulating agents (ESAs) to chronic kidney disease (CKD) patients with hemoglobin levels greater than or equal to 10 g/dL without symptoms of anemia (2012)

Europe

●European Renal Best Practice (ERBP): A position statement for anaemia management in patients with chronic kidney disease (2009)

United Kingdom

●National Institute for Health and Care Excellence (NICE): Guideline on chronic kidney disease – Assessment and management (2021)

●The Renal Association (RA): Clinical practice guideline – Anaemia of chronic kidney disease (2017, updated 2020)

Australia-New Zealand

●Kidney Health Australia-Caring for Australasians with Renal Impairment (KHA-CARI): Guideline ─ Biochemical and haematological targets: Haemoglobin concentrations in patients using erythropoietin stimulating agents (2011)

Japan

●[In English] Japanese Society for Dialysis Therapy (JSDT): Guidelines for renal anemia in chronic kidney disease (2015)

●[In Japanese] Japanese Society for Dialysis Therapy (JSDT): Guidelines for renal anemia in chronic kidney disease (2015)